Abstract
A prospective, randomized trial in which 236 patients received oral levofloxacin, either at 600 mg/day for 1 day (n=124) or 300 mg/day for 3 days (n=112). Urinalysis, plasma white blood cell count (WBC) (per mm3), and C reactive protein (CRP) (mg/dl) levels were checked before prostate biopsy (PBX), on the day after PBX, and on the seventh day after PBX. Two patients (1.61%) who received 600 mg for 1 day and 2 patients (1.79%) who received 300 mg for 3 days had febrile infectious complications. There was no statistically significant difference between levofloxacin at 600 mg for 1 day and levofloxacin at 300 mg for 3 days regarding the elevation of WBC and CRP. We can perform PBX safely with levofloxacin at 600 mg for 1 day as prophylaxis and recommend this method from the point of view of the decrease of antibiotic-resistant strains.
Similar content being viewed by others
References
Aron M, Rajeev TP, Gupta NP (2000) Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study. BJU Int 85:682–685
Bishop D, Oliver J (1977) A study of transrectal aspiration biopsies of the prostate, with particular regard to prognostic evaluation. J Urol 117:313–315
Brewster SF, MacGowan AP, Gingell JC (1995) Antimicrobial prophylaxis for transrectal prostatic biopsy: a prospective randomized trial of cefuroxime versus piperacillin/tazobactam. Br J Urol 76:351–354
Carey JM, Korman HJ (2001) Transrectal ultrasound guided biopsy of the prostate. Do enemas decrease clinically significant complications? J Urol 166:82–85
Onder AU, Yaycioglu O, Ataus S, Gul U, Demirkesen O, Yalcin V, Solok V (2003) Transition zone biopsy and prediction of extraprostatic extension at radical prostatectomy. Int J Urol 10:302–308
Cormio L, Berardi B, Callea A, Fiorentino N, Sblendorio D, Zizzi V, Traficante A (2002) Antimicrobial prophylaxis for transrectal prostatic biopsy: a prospective study of ciprofloxacin vs piperacillin/tazobactam. BJU Int 90:700–702
Crawford ED, Haynes AL Jr, Story MW, Borden TA (1982) Prevention of urinary tract infection and sepsis following transrectal prostatic biopsy. J Urol 127:449–451
Davis R, Bryson HM (1994) Levofloxacin. A review of its antibacterial activity, pharmacokinetics, and therapeutic efficacy. Drugs 48:132
Desmond PM, Clark J, Thompson IM, Zeidman EJ, Mueller EJ (1993) Morbidity with contemporary prostate biopsy. J Urol 150:1425–1426
Drusano GL, Preston SL, Van Guilder M (2000) A population pharmacokinetic analysis of the penetration of the prostate by levofloxacin. Antimicrob Agents Chemother 44:2046–2051
Fournier G, Valeri A, Mangin P, Cussenot O (2004) Prostate cancer: diagnosis and staging. Ann Urol (Paris) 38:207–224
Fujimoto N, Harada S, Sato H, Akasaka S, Nomura M, Yamada Y, Ueno Y, Matsumoto T (2004) Screening for prostate cancer in Yahata, Kitakyushu. J UOEH 26:239–244
Griffith BC, Morey AF, Ali-Khan MM, Canby-Hagino E, Foley JP, Rozanski TA (2002) Single dose levofloxacin prophylaxis for prostate biopsy in patients at low risk. J Urol 168:1021–1023
Isen K, Kupeli B, Sinik Z, Sozen S, Bozkirli I (1999) Antibiotic prophylaxis for transrectal biopsy of the prostate: a prospective randomized study of the prophylactic use of single dose oral fluoroquinolone versus trimethoprim-sulfamethoxazole. Int Urol Nephrol 31:491–495
Kapoor DA, Klimberg IW, Malek GH, Wegenke JD, Cox CE, Patterson AL, Graam E, Echols RM, Whalen E, Kowalsky SF (1998) Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy. Urology 52:552–558
Larsen EH, Gasser TC, Madsen PO (1986) Antimicrobial prophylaxis in urologic surgery. Urol Clin North Am 4:591–604
Lindert KA, Kabalin JN, Terris MK (2000) Bacteremia and bacteriuria after transrectal ultrasound guided prostate biopsy. J Urol 164:76–80
Onder AU, Yaycioglu O, Ataus S, Gul U, Demirkesen O, Yalcin V, Solok V (2003) Transition zone biopsy and prediction of extraprostatic extension at radical prostatectomy. Int J Urol 10:302–308
Packer MG, Russo P, Fair WR (1984) Prophylactic antibiotics and Foley catheter use in transperineal needle biopsy of the prostate. J Urol 131:687–689
Sieber PR, Rommel FM, Agusta VE, Breslin JA, Huffnagle HW, Harpster LE (1997) Antibiotic prophylaxis in ultrasound guided transrectal prostate biopsy. J Urol 157:2199–2200
Turner B, Warner J, Rhamy R (1980) Prostatic needle examination. South Med J 73:183–184
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shigemura, K., Tanaka, K., Yasuda, M. et al. Efficacy of 1-day prophylaxis medication with fluoroquinolone for prostate biopsy. World J Urol 23, 356–360 (2005). https://doi.org/10.1007/s00345-005-0024-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-005-0024-4